Hostname: page-component-8448b6f56d-qsmjn Total loading time: 0 Render date: 2024-04-24T16:31:19.681Z Has data issue: false hasContentIssue false
  • English
  • Français

Prochlorperazine (Stemetil) in Mental Deficiency

Published online by Cambridge University Press:  08 February 2018

T. L. Pilkington
T. L. Pilkington*
Affiliation:
Glenfrith Hospital, Leicester
Get access Rights & Permissions [Opens in a new window]

Extract

The use of tranquillizers in mental deficiency has shown a divergency of effects. Noce, Williams and Rapaport (1) claimed that reserpine produced some improvement in all their thirteen adult hyperactive low-grades, and Rettig (2) reported that chlorpromazine produced decreased hyperactivity in twenty-three of his twenty-seven adult defectives of all grades. Blair and Herold (3), using ten “matched-pairs” of hyperactive defective children, found behaviour improvements in nine of them on chlorpromazine, with an average I.Q. gain of 10.4. Using six different tranquillizers on twenty-five adult defectives of all grades, Rudy, Himwich and Rinaldi (4), found that all gave some benefit, with chlorpromazine the most effective. Fischer (5) showed that twenty out of his twenty-two low-grade adult defectives (many with psychotic overlay) were improved in behaviour on reserpine. Using sixteen “matched-pairs” of E.S.N. children, Segal and Tansley (6) claimed that hydroxyzine produced improved scholastic performance in fourteen of them, and Bergin and Bergin (7) stated that the epileptics in particular in their thirty-four low-grades were improved by promazine hydrochloride.

Type
Original Articles
Information
Journal of Mental Science , Volume 105 , Issue 438 , January 1959 , pp. 215 - 219
Copyright
Copyright © Royal College of Psychiatrists, 1959 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Noce, R. H., Williams, D. B., and Rapaport, W., “Reserpine (Serpasil) in the Management of the Mentally Ill and Mentally Retarded”, J. Amer. Med. Ass., 1954, 156, 9.CrossRefGoogle Scholar
2. Rettig, J. H., “Chlorpromazine for the Control of Psychomotor Excitement in the Mentally Deficient”, J. Nerv. and Ment. Dis., 1955, 122, 2.CrossRefGoogle Scholar
3. Blair, H. V., and Herold, W., “Efficacy of Chlorpromazine in Hyperactive Mentally Retarded Children”, Arch. Neurol. and Psych., 1955, 74, 4.Google Scholar
4. Rudy, L. H., Himwich, H. E., and Rinaldi, F., “A Clinical Evaluation of Psycho-pharmacological Agents in the Management of Disturbed Mentally Defective Patients”, Amer. J. Ment. Def., 1958, 62, 5.Google Scholar
5. Fischer, E., “Reserpine (Serpasil) in Mental Deficiency Practice”, J. Ment. Sci., 1956, 102, 428.CrossRefGoogle Scholar
6. Segal, L., and Tansley, A. E., “A Clinical Trial of Hydroxyzine (‘Atarax’) on a Group of Maladjusted E.S.N. Children”, ibid., 1957, 103, 432.Google Scholar
7. Bergin, J. T. F., and Bergin, Mary M., “The Use of Sparine in Low-Grade Mental Defectives”, J. Irish. Med. Ass., 1958, 52, 247.Google Scholar
8. Gillie, Anne K., “The Use of Pacatal in Low-Grade Mental Defectives”, J. Ment. Sci., 1957, 103, 431.Google Scholar
9. Craft, M., “Tranquillisers in Mental Deficiency: Hydroxyzine”, ibid., 1957, 103, 433.Google Scholar
10. Idem , “Tranquillisers in Mental Deficiency: Chlorpromazine”, J. Ment. Def. Research, 1957, 1, 2.Google Scholar
11. Milne, H. B., and Berliner, F., “A Clinical Trial of Stemetil”, J. Ment. Sci., 1958, 104, 436.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.